![From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications - eBioMedicine From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications - eBioMedicine](https://www.thelancet.com/cms/asset/28c85da9-dc0d-4201-aa83-5d249291644f/gr1.jpg)
From single-target to cellular niche targeting in Crohn's disease: intercepting bad communications - eBioMedicine
![COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/11/front_matter-JCC-Journal-pdf.jpg)
COVID-19 and IBD: Guidance from IOIBD and ECCO on management of patients | International Organization For the Study of Inflammatory Bowel Disease
![Management of IBD during the COVID-19 outbreak: resetting clinical priorities | Nature Reviews Gastroenterology & Hepatology Management of IBD during the COVID-19 outbreak: resetting clinical priorities | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-020-0294-8/MediaObjects/41575_2020_294_Fig1_HTML.png)
Management of IBD during the COVID-19 outbreak: resetting clinical priorities | Nature Reviews Gastroenterology & Hepatology
Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper
![PredictImmune Ltd on Twitter: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for PredictImmune Ltd on Twitter: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for](https://pbs.twimg.com/media/EZGMSJWWsAASsuT.jpg)
PredictImmune Ltd on Twitter: "#ThrowbackThursday to our poster from ECCO 2020, which details our health economic analysis showing how @PredictSUREIBD offers a cost-effective way to help doctors choose the right treatment for
![ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease](https://ioibd.org/wp-content/uploads/2020/04/news-ecco-1080x675.jpg)
ECCO update on COVID-19 and IBD | International Organization For the Study of Inflammatory Bowel Disease
![PROMs: early benefits for care of IBD outpatients who directly report their symptoms via digital tablet - UK IBD Registry PROMs: early benefits for care of IBD outpatients who directly report their symptoms via digital tablet - UK IBD Registry](https://ibdregistry.org.uk/wp-content/uploads/2020/02/Pearl-Avery-clinical-nurse-specialist-Dorest-County-Hospital-225x300.jpg)
PROMs: early benefits for care of IBD outpatients who directly report their symptoms via digital tablet - UK IBD Registry
![Cancers | Free Full-Text | Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy Cancers | Free Full-Text | Management of Inflammatory Bowel Disease in Patients with Current or Past Malignancy](https://www.mdpi.com/cancers/cancers-15-01083/article_deploy/html/images/cancers-15-01083-g001.png)